[ad_1] PALO ALTO, Calif., Nov. 7, 2025 /PRNewswire/ — Evommune, Inc. (“Evommune”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the closing of its initial public […]
Tag: Evommune
Evommune Announces Pricing of its Initial Public Offering
[ad_1] PALO ALTO, Calif., Nov. 5, 2025 /PRNewswire/ — Evommune, Inc. (“Evommune”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the pricing of its initial public […]
